Trans-Hi™ is a superior transfection reagent capable to compete against the leading products on the market. It is based on a proprietary polymer technology. It forms stable nanoparticles with DNA and rapidly releases the DNA molecules upon endocytosis into the cytoplasm. It is a broad spectrum transfection regent offering superior and reproducible transfection efficiency on the common cells such as Hela, CHO, HEK293 and many hard-to-transfect mammalian cells with minimal toxicity. Trans-Hi™is very cost-efficient and 1.0mL is sufficient for over 660 transfections in 24 well plates.

Key Features for Trans-Hi^TM

• Excellent transfection for single DNA transfection or multi DNA co-transfection
• Rapid onset and long-lasting transfection
• Suitable for very long DNAs
• Simple and easy to use transfection procedure
• Robust and reproducible transfection
• High level of recombinant protein production
• Very cost efficient
• Long shelf-life: 12 months

Specifications:

Protocols

Trans-Hi™General Protocol For In Vitro Transfection in Mammalian Cells

Trans-Hi™ - Protocol for Transfecting 293 and CHO Suspension Cells

Trans-Hi™ - Protocol for Generation of rAAV

Trans-Hi™-Technical Tips For Good In Vitro Transfection

Comparison study ofIn vitro plasmid DNA transfection of Trans-Hi^TM and Lipofectamine®2000in HEK293T cells with GFP vector using the manufacture recommended reagent/DNA ratio of 3:1 (µL/µg) and 0.5µg DNA per wellused for both products in 24 well plate 30 hours post transfection.

Trans-Hi™/DNA ratio (µL/µg) (HEK293T)

Study of the transfection efficiency as a function of transfection reagent/DNA ratio indicating optimal tranfection efficiency achieved at Trans-Hi™/DNA ratio of 3:1 (µL/µg) (HEK293T cells in24 well plate 30 hours post transfection, 0.5ug DNA per well).

Head-to-head comparisonTrans-Hi™ against Lipofectamine 2000HEK293A cells with GFP vector (reagent/DNA ratio of 3:1(µL/µg, 0.5ug per well), 24 well plate 48 hours post transfection).

Comparison study ofIn vitroplasmid DNA transfection of Trans-Hi™and Lipofectamine®2000in Hela cellswith GFP vector ((reagent/DNA ratio of 3:1(µL/µg, 0.5ug per well),24 well plate 48 hours post transfection).

Broad Transfection Spectrum for Mammalian Cell Types

FormuMax科学公司位于加利福尼亚州北部硅谷的中心地带，是一家专业的药品配送公司，致力于满足医药/生物技术、化妆品和保健工业的配方开发外包的日益增长的需求。经营理念是成为**的伙伴，作为药物交付的***，特别是在制定具有挑战性的化合物脂质体和其他新的纳米技术。FormuMax拥有一支技术团队，在药物递送领域拥有***的专业知识，特别关注脂质体和其他基于脂质的技术。它们目前提供基础研究，配方可行性，定制配方准备，配方表征和分析科学的合同服务。FormuMax是**家提供大量预成型脂质体试剂的在线商店。已经成功地为来自世界各地的大学实验室、研究中心和各种行业的客户提供了服务和/或产品。 

FormuMax供应主要产品：

Clophosome-氯膦酸盐脂质体

FormuMax提供两种预埋有氯磷酸盐分子的中性脂质体产品，该产品单次静脉或腹腔注射后可在脾脏经巨噬细胞清除率可达80-90%，并具有高度活性、稳定的理化性质（长期冰箱存放后仍保持均一性及悬浮特性），粘滞度低使用简便，适用于静脉、腹腔、皮下、鼻腔、气管等多种方式给药。

Doxoves-盐酸多柔比星脂质体

FormuMax可提供脂质定制的盐酸多柔比星脂质体（定制内容为脂质成分及脂质体大小）。FormuMax提供的产品为Doxoves，具有高度的产品稳定性和一致性,紧密的粒径分布和高效的药物包埋效率（高达4.0mg/mL(40mMlipid)的包埋药物浓度）。Doxoves系列产品在产品特性、稳定性及药代动力学特性上可媲美商业产品Doxil。

DrugLoadedliposomes

FormuMax提供多款包埋活性药物的脂质体产品，包括DoxorubicinHCl（含2.0mg/mL及4.0mg/mL两种浓度），IrinotecanHCl(2.0mg/mL)，TopotecanHCl(2.0mg/mL)，产品线仍在持续更新中。

预制脂质体

FormuMax供应的预制脂质体产品囊括多种通用的脂质体类型，使用世界*的优质脂类原料。该系列产品易于使用，稳定性、可靠性及可重复性高，节省时间和成本，并可为研究人员提供定制脂质体服务。目前FormuMax提供聚乙二醇化/非聚乙二醇化的常用脂质体，以及含浓度梯度Ammonium的脂质体

阳离子脂质体

FormuMax供应一系列的阳离子脂质体，用于需带正电荷的脂质体或细胞转染质粒DNA、反义/干扰RNA等。

荧光脂质体

FormuMax供应预制荧光标记的脂质体，包括常规荧光脂质体、生物素化的荧光脂质体以及Avdinized化的荧光脂质体，另外还提供客户定制的荧光脂质体（脂类及染料可选）。

脂质体制备薄膜

FormuMax供应一系列不同规格的聚碳酸酯薄膜，用于脂质体挤出制备。